Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of epirubicin, cisplatin and capecitabine as
neoadjuvant therapy prior to radical resection in patients with newly diagnosed operable
oesophageal adenocarcinoma.